The University of Manchester - Proximity to Discovery: Industry Engagement Fund - Phase 3

Lead Research Organisation: University of Manchester

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The MRC Proximity to Discovery scheme awards universities funds to help develop new collaborations, and ways of exchanging knowledge and skills.  The awards can be used to support activities that promote the value of academic-industry partnership, and enhance academic and industry researchers’ understanding of each other’s needs and capabilities.  This may be through people exchanges, creation of technology demonstrators, showcase events, commercialisation workshops and ‘entrepreneurs in residence’ schemes.  Such exchanges of knowledge and skills will boost the most fruitful collaborations between UK universities and life science companies.

Publications

10 25 50
 
Description Collaboration between Dr David Brough and Astex Pharmaceuticals 
Organisation Astex Pharmaceuticals
Country United States 
Sector Private 
PI Contribution Preparing the grounds for a framework agreement between DNEP/NMHD and Astex
Collaborator Contribution Awaiting final report
Impact Awaiting Final Report
Start Year 2017
 
Description Collaboration between Dr Helen Hawley-Hague and Philips 
Organisation Koninklijke Philips Electronics N.V.
Department Philips
Country Global 
Sector Private 
PI Contribution Exploring the acceptability and potential impact of the use of predictive analytics in the prevention of falls and the management of long-term conditions.
Collaborator Contribution Project ongoing
Impact Awaiting project completion and final report
Start Year 2017
 
Description Collaboration between Dr Jordi Bella and Biogelx 
Organisation Biogelx
Country United Kingdom 
Sector Private 
PI Contribution Preparing the grounds for a framework agreement between DNEP/NMHD and Astex
Collaborator Contribution Project Ongoing
Impact Awaiting Project completion and final report
Start Year 2017
 
Description Collaboration between Prof Mark Dunne and Heptares 
Organisation Heptares Therapeutics Ltd
Country United Kingdom 
Sector Private 
PI Contribution Novel islet cell targets for metabolic diseases associated with hypoglycaemia
Collaborator Contribution Awaiting final report
Impact Project ongoing
Start Year 2017
 
Description Collaboration between Prof Mark Dunne and Zealand Pharma 
Organisation Zealand Pharma
Country Denmark 
Sector Private 
PI Contribution The Development of Translational Data sets for Use in the Treatment of Hypoglycaemia
Collaborator Contribution Consumables, and access to technology and industry expertise
Impact Project ongoing
Start Year 2017
 
Description Collaboration between Prof Sue Kimber and Randox 
Organisation Randox Laboratories
Country Global 
Sector Private 
PI Contribution Industry secondment of PDRA from UoM to Randox Laboratories, to extract industry expertise and progress the development of a novel pluripotency biomarker for use as a commercial antibody assay.
Collaborator Contribution Randox provided expertise around the area of commercial antibody production, and donated time in their laboratory and some consumables.
Impact Following the completion of the project, the PI is currently writing a paper for publication, and Randox have offered to file the patent and cover associated costs. . This is around novel biomarker combinations for the identification of pluripotency and very early identification of loss of pluripotency.
Start Year 2017
 
Description Collaboration between Prof Tjeerd Van Staa and Imosphere 
Organisation Imosphere Ltd
PI Contribution Exploring new methods for clinical sample preparation with diagnostic potential
Collaborator Contribution Project ongoing
Impact Awaiting project completion and final report
Start Year 2017